A Open-Label, Multiple Ascending Dose Study of DS-3078a, an Oral TORC1/2 Kinase Inhibitor, in Subjects With Advanced Solid Tumors or Lymphomas
Clinical trial NCT01588678 · COMPLETED
Trial details
- NCT number
- NCT01588678
- Sponsor
- Daiichi Sankyo
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2014-06-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.